Cowen and Company’s Viatris VTRS Stock Holding History

Cowen and Company’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,939	Closed	-$94K	–	738
2021 Q4	$94K	Buy	6,939 +4,991	+256%	+$66.6K	0.01%	377
2021 Q3	$26K	Buy	+1,948	New	+$27.6K	﹤0.01%	461
2021 Q2	–	Sell	-4,775	Closed	-$67K	–	707
2021 Q1	$67K	Buy	+4,775	New	+$77.8K	﹤0.01%	360

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Cowen and Company's VTRS Position: Q1 2022 in Review

Cowen and Company sold out of Viatris (VTRS) in Q1 2022, closing a stake of 6,939 shares — an estimated $94K sold.

Cowen and Company first reported a position in VTRS in Q1 2021 and held it in 3 quarters. The position peaked at $94K in Q4 2021. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q1 2022.

Cowen and Company reported no remaining Viatris position as of Q1 2022 after selling out during the quarter.
Cowen and Company sold 6,939 Viatris shares in Q1 2022, an estimated $94K.
Cowen and Company first reported a position in Viatris in Q1 2021 and held it in 3 quarters.
Cowen and Company's Viatris position peaked at $94K in Q4 2021.
1,022 funds tracked by Wall St. Rank held Viatris as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.